Although local anesthetics are considered primarily Na ϩ channel blockers, previous studies suggest a common intracellular site of action on different G protein-coupled receptors. In the present study, we characterized this site for the LPA, m1 muscarinic, and trypsin receptor. Xenopus laevis oocytes expressing endogenous LPA and trypsin or recombinant m1 receptors were two-electrode voltage clamped. We studied LPA inhibition in the presence of ropivacaine stereoisomers to determine whether LA act on a protein site. Ropivacaine inhibited LPA signaling in a stereoselective and noncompetitive manner, suggesting a protein interaction. Antisense injection was used to characterize G protein ␣-subunits involved in mediation of LPA, m1, trypsin, and angiotensin 1A receptor signaling. Lidocaine and its analog QX314 were injected into oocytes expressing these receptors to examine a potential role for specific G protein ␣-subunits as targets for LA. G␣ q was shown to be among the primary G protein subunits mediating the LPA, m1, and trypsin receptor signaling, all of which were inhibited to a similar degree by intracellular injected QX314 (424 ϫ 10 Ϫ6 M). Since the angiotensin 1A receptor, previously shown not to be affected by LA, was found not to signal via G␣ q , but via G␣ o and G␣ 14 , the intracellular effect of LA most likely takes place at the G␣ q -subunit.
Although blockade of Na ϩ channels is the primary mode of local anesthetic action, in the past decade alternative actions of LA have increasingly become a topic of investigation and may lead to new clinical uses for these compounds (such as anti-inflammatory indications). We have previously reported inhibitory effects of LA on several G protein-coupled receptors, such as thromboxane A 2 , m1 muscarinic acetylcholine (Hollmann et al., 1999) , and in particular LPA receptors . LPA is likely to be a wound-healing mediator, making such investigations particularly relevant, because LA are used frequently for injection around surgical wounds. We have shown that lidocaine or bupivacaine inhibits LPA, but not angiotensin, signaling. QX314 (a permanently charged and hence membrane-impermeant lidocaine analog) inhibited LPA signaling only when injected intracellularly, and benzocaine (permanently uncharged LA) inhibited with a similar half-maximal inhibitory concentration (IC 50 ). Combined administration of both compounds exerted superadditive effects, suggesting the presence of two different binding sites for LA, one of which is intracellular (Sullivan et al., 1999) . Downstream signaling induced by inositol trisphosphate or guanosine-5Ј-O-(3-thio)triphosphate (Sullivan et al., 1999) was not affected by LA , suggesting that the action of LA is on the receptor or coupled G protein. However, nonspecific membrane actions of LA are possible, and we did not directly confirm a protein site of action in our previous studies. Comparison of the effects of intracellular QX314 on m1 muscarinic and LPA receptors showed not only very similar calculated IC 50 values, but also similar maximal degree of inhibition and slope of the inhibition curve (Hollmann et al., 1999) , suggesting a common site of action. No similarity exists between the receptors, but because they couple to similar G proteins, we hypothesized that LA may inhibit G protein function.
In the present study we tested this hypothesis. Specifically, we 1) determined stereoselectivity of LA effect to investigate whether LA act on a protein site; 2) determined the G protein subtypes coupling to LPA, m1 muscarinic, trypsin, and angiotensin 1A receptors; and 3) determined whether specific G protein ␣-subunits are involved in the LA effect.
Experimental Procedures
The studies were performed in Xenopus laevis oocytes. These cells express endogenous LPA and trypsin receptors; other G protein-coupled receptors can be expressed conveniently. Intracellular Ca 2ϩ release as a response to receptor stimulation is easily assessed as Ca 2ϩ -activated Cl Ϫ currents. The size of the cells makes intracellular injection straightforward. In addition, using oocytes allowed comparison with our previous results obtained in this model. The study protocol was approved by the Animal Research Committee at the University of Virginia.
Materials. Molecular biology reagents were obtained from Promega (Madison, WI), and other chemicals were obtained from Sigma (St. Louis, MO). QX314 and the stereoisomers of ropivacaine were a gift from Astra Pharmaceuticals, L.P. (Westborough, MA).
Oocyte harvesting, receptor expression, electrophysiologic recording, and intracellular injections were performed as described previously (Durieux et al., , 1994 Chan and Durieux, 1997; Nietgen et al., 1997; Sullivan et al., 1999) .
Oligonucleotide Injection. Phosphorothioate oligonucleotides were synthesized by the University of Virginia Research Facility. The antisense sequences, shown in Fig. 2A , are complementary to specific 20-base segments with less than 50% homology with other types of X. laevis G ␣ proteins (from Shapira et al., 1999) . Sense oligonucleotides were used as control. Uninjected oocytes (for experiments on the LPA or endogenous protease receptor) or those injected 24 h prior with cRNA encoding the m1 or AT 1A receptor were injected with 50 nl of sterile water containing 50 ng/cell antisense or sense oligonucleotides. Control cells were injected with the same amount of sterile water. Twenty-four and 48 h after oligonucleotide injection, the cells were tested as described below.
Analysis. Results are reported as mean Ϯ S.E.M. At least 12 oocytes were used to determine each data point unless noted otherwise. As variability between batches of oocytes is common, responses were at times normalized to control response. Statistical tests used are indicated under Results. p Ͻ 0.05 was considered significant. Concentration-response curves were fit to the following logistic function, derived from the Hill equation: y ϭ y min ϩ (y max Ϫ y min ) {1Ϫ X n /(X 50 n ϩ x n )} where y max and y min are the maximum and minimum response obtained, n is the Hill coefficient, and X 50 is the halfmaximal effect concentration (EC 50 ) for agonist or the half-maximal inhibitory effect concentration (IC 50 ) for antagonist.
Results
LPA Responses in X. laevis Oocytes. To provide baseline measurements and to assure that our model behaved similar to our previous studies, we determined the concentration-response relationship for LPA. LPA induced inward currents as described previously by us (Durieux et al., 1992; Chan and Durieux, 1997) and others (Fernhout et al., 1992; Guo et al., 1996; Liliom et al., 1996; Kakizawa et al., 1998; Noh et al., 1998) (Fig. 1A) . As shown in Fig. 1B , the response to LPA was concentrationdependent. Half-maximal effect concentration (EC 50 ) was 6.0 Ϯ 3.3 ϫ 10 Ϫ7 M. Maximal responses of 4.3 Ϯ 0.5 C were obtained at a LPA concentration of 10 M. Calculated E max was 5.1 Ϯ 0.5 C and Hill coefficient was 0.57 Ϯ 0.08. These findings compare closely with data reported in our previous studies (Durieux, 1995; Durieux and Nietgen, 1997; Nietgen et al., 1997 Nietgen et al., , 1998 .
Ropivacaine Stereoselectively Inhibits LPA Receptor Function. To determine whether LA inhibition of LPA signaling takes place at a protein site, we studied stereoselectivity of LA action. We selected S(Ϫ) and R(ϩ)-ropivacaine for these experiments. Both stereoisomers concentration dependently inhibited functioning of LPA receptors (e.g., Figure 1C) activated by LPA at EC 50 (6.0 ϫ 10 Ϫ7 M; Fig. 1D . These results demonstrate that LPA signaling is inhibited by ropivacaine enantiomers in a stereoselective manner. Although an action on an organized (and hence stereoselective) lipid membrane can not be ruled out by these experiments, the data are compatible with a protein interaction for ropivacaine, as suggested for other LA in our previous studies .
Our data show that S(Ϫ)-ropivacaine, the clinically relevant enantiomer, is approximately 6-fold less potent than bupivacaine and 4-fold less potent than lidocaine in blocking LPA signaling . Like bupivacaine, S(Ϫ)-ropivacaine inhibited in a noncompetitive manner (Fig. 1E) . EC 50 for LPA in the presence of S(Ϫ)-ropivacaine at IC 50 (23.8 ϫ 10 Ϫ3 M) was 1.7 Ϯ 0.9 ϫ 10 Ϫ7 M; this was not significantly different from the EC 50 of 1.6 Ϯ 0.2 ϫ 10 Ϫ7 M obtained under control conditions (p ϭ 0.744, t test). In contrast, E max was reduced by the presence of S(Ϫ)-ropivacaine from 1.1 Ϯ 0.1 to 0.6 Ϯ 0.03
Functional Degradation of G Protein ␣-Subunits by Injection of Antisense Oligonucleotides. Stereoselectivity of ropivacaine block is compatible with our hypothesis that G proteins are a target site in the inhibitory effect of LA on LPA signaling. We therefore determined whether receptors inhibited by LA share a common coupled G␣-subunit, by selectively depleting G␣ proteins using antisense oligonucleotides directed against the G protein subunits. To verify that this system functioned appropriately in our hands, we determined the G protein ␣-subunits coupling to 1) endogenous protease receptors and 2) recombinantly expressed m1 muscarinic receptors in X. laevis oocytes. We studied these receptor systems previously (Hollmann et al., 1999) , and the G protein ␣-subunits coupling to these receptors have been determined previously by others allowing verification of the technique (Shapira et al., 1999) . Since the receptors of interest induce intracellular Ca 2ϩ release, we used antisense oligonucleotides directed against G␣ q , G␣ 11 , G␣ 14 , and G␣ o . Oocytes injected with vehicle served as control.
First, we determined the G protein ␣-subunits coupling to the endogenous protease receptor. We reported previously that the protease trypsin induces Ca 2ϩ -activated Cl Ϫ current in oocytes (Durieux et al., 1994) . The site of action of trypsin was extracellular, the response desensitized completely, and the suggested mechanism was the presence of a protease receptor on the oocyte. As in our previous study, trypsin (1 g/ml) induced responses in oocytes similar to those induced by LPA (data not shown). As shown in Fig. 2B , responses elicited by trypsin (1 g/ml) 24 h after injection of antisense oligonucleotides were not affected by anti-G␣ o (90 Ϯ 19% of control response, p Ͼ 0.05; unless otherwise stated, all determinations of G protein ␣-subunits were compared by oneway analysis of variance with Dunnett correction) or anti-G␣ 11 (81.3 Ϯ 16.6% of control response, p Ͼ 0.05). In contrast, oocytes injected 24 h before measurement with anti-G␣ q (32.4 Ϯ 6.2% of control response, p Ͻ 0.05) or anti-G␣ 14 (45.2 Ϯ 8.6% of control response, p Ͻ 0.05) showed a signif- icantly inhibited response to trypsin. Nearly identical results were obtained when experiments were performed 48 h after antisense injection (data not shown). These results indicate that the response evoked by trypsin is mediated by G␣ q and G␣ 14 , suggesting strongly that the trypsin response is mediated by a G protein-coupled receptor system.
Next we investigated the G protein ␣-subunit coupling of m1 muscarinic responses elicited by stimulation with MCh at EC 50 [5.7 ϫ 10 Ϫ7 M, calculated from our previous investigations (Hollmann et al., 1999) ] in oocytes injected previously with m1 receptor cRNA. Experiments were performed 48 h after antisense injection. Injection of anti-G␣ q (44.9 Ϯ 8.5% of control response) or anti-G␣ 11 (47.2 Ϯ 8.3% of control response) affected MCh-induced responses significantly (p Ͻ 0.05), whereas anti-G␣ o -injected (92.2 Ϯ 12.7% of control response) or anti-G␣ 14 -injected (98.9 Ϯ 5.5% of control response) oocytes showed responses not significantly different from those observed in control cells (p Ͼ 0.05) (Fig. 2C ). Our results show that muscarinic m1 signaling is mainly mediated by G␣ q and G␣ 11 .
The studies using trypsin and muscarinic receptors demonstrate that G␣ protein depletion by antisense oligonucleotides functions appropriately in our hands, as results are similar to those obtained by Shapira et al. (1999) . These investigators demonstrated additionally that the reduced functional responses are associated with decreased mRNA and protein levels for the respective G proteins. After these confirmatory experiments, we proceeded to determine the G␣ proteins mediating the LPA response.
G␣ q and G␣ o Mediate the Response to LPA in X. laevis Oocytes. To exclude the possibility that injection of DNA oligonucleotides per se affects responses to LPA (at EC 50 , 6.0 ϫ 10 Ϫ7 M), we first studied the effects of sense oligonucleotide injection. Neither after 24 (data not shown) nor after 48 h (Fig. 2D ) did sense-injected oocytes show responses different from those obtained in control oocytes Ϫ7 M; ---, in the presence of ropivacaine 24 mM, EC 50 1.6 Ϯ 0.2 ϫ 10 Ϫ7 M). Maximal effect concentration (E max ) was significantly reduced after S(Ϫ)-ropivacaine administration (1.1 Ϯ 0.1 to 0.6 Ϯ 0.03 A), making a noncompetitive antagonism most likely. injected with sterile water (p Ͼ 0.05). Thus, sense oligonucleotides have no effect.
Antisense injection 48 h (Fig. 2E ) before oocytes were tested caused a significant (p Ͻ 0.05) inhibition of peak current when anti-G␣ o (38.1 Ϯ 3.9% of control response) or anti-G␣ q (41.7 Ϯ 4.9% of control response) were used. In contrast, injection of anti-G␣ 11 (102 Ϯ 17% of control response) or anti-G␣ 14 (109 Ϯ 21% of control response) was without significant (p Ͼ 0.05) effect compared with control oocytes (100 Ϯ 19.3%). These findings indicate that LPA signaling is mediated primarily by G␣ q and G␣ o .
Since m1 muscarinic and LPA signaling are similarly inhibited by intracellular QX314, our findings suggest that the G␣ q protein, common to both signaling pathways, might be the target of the LA. This hypothesis was tested in the next series of experiments.
QX314 Inhibition of LPA Signaling Requires G␣ q . We investigated whether LA inhibit LPA signaling by an action on G protein ␣-subunits. To exclude an extracellular LA effect, we chose the permanently charged and therefore membrane-impermeant lidocaine analog QX314 for our experiments and applied it intracellularly. First, we determined the inhibition curve for intracellularly injected QX314 on LPA responses induced by stimulation with LPA (10 Ϫ7 M). We chose an LPA concentration somewhat less than EC 50 because injection of 150 nM KCl (50 nl) used in control cells and in treatment cells as buffer for QX314 caused substantially increased response sizes as a result of the increased intracellular Cl Ϫ load. Figure 3A presents the results. Fitting to the Hill equation revealed a calculated IC 50 of 424 Ϯ 70 ϫ 10 Ϫ6 M, which is close to the value reported by Sullivan et al. (1999) . Mean size of the control response was 3.6 Ϯ 0.3 A. To assure that QX314 effect is not dependent on response size, we also studied its action on responses elicited by a low concentration of LPA (1 nM). In control cells mean peak current was 1.1 Ϯ 0.2 A (Fig. 3B) . Injection of QX314 at IC 50 (424 ϫ 10 Ϫ6 M) caused an inhibition to approximately 38% (0.4 Ϯ 0.1 A), showing that the effect of the compound is independent of LPA response size.
We then tested the inhibitory effect of intracellularly injected QX314 at IC 50 (424 ϫ 10 Ϫ6 M) on oocytes injected 48 h prior with anti-G␣ q or anti-G␣ o , which, as shown above, mediate the LPA response. Oocytes were stimulated with 0.1 M LPA. As shown in Fig. 3C , significant inhibition of LPA responses by intracellularly injected QX314 was obtained only in anti-G␣ o -injected cells (0.7 Ϯ 0.1 versus 2.0 Ϯ 0.1 A, Fig. 2 . Selective G␣-subunit depletion using antisense constructs. A, antisense oligonucleotide sequence used (Shapira et al., 1999) . B, mean Ϯ S.E.M. of peak currents of trypsin-induced (1 g/ml) inward chloride current [I Cl(Ca) ] in control oocytes (filled column) and cells injected with DNA antisense oligonucleotides (50 ng/ oocyte) targeted against specific G␣-subunits, 24 h before experiments. Mean Ϯ S.E.M. of control currents was 1.4 Ϯ 0.3 A. Each data point includes at least 24 oocytes. C, MCh at EC 50 -induced (5.7 Ϯ 5.2 ϫ 10 Ϫ7 M) I Cl(Ca) in control oocytes (filled column, 0.4 Ϯ 0.1 A) and cells tested 48 h after injection of antisense constructs. D, effects of sense oligonucleotide (see Fig. 2A for sequences) injection 24 h prior on LPA signaling, stimulated by LPA at EC 50 (6.0 Ϯ 3.3 ϫ 10 Ϫ7 M). At neither time point did sense oligonucleotide-injected oocytes show a significant difference in response compared with sterile water-injected control oocytes [1.9 Ϯ 0.1 A (24 h) and 1.5 Ϯ 0.2 A (48 h)]. E, Mean Ϯ S.E.M. of peak currents of LPA responses induced by LPA at EC 50 (6.0 Ϯ 3.3 ϫ 10 Ϫ7 M) in control oocytes (filled column, 1.8 Ϯ 0.3 A) and cells injected with the corresponding DNA antisense oligonucleotides (50 ng/oocyte) 48 h prior. Anti-G␣ o inhibited responses to 38.1 Ϯ 3.9%, anti-G␣ q to 41.7 Ϯ 4.9% as compared with control. In contrast, injection of anti-G␣ 11 (102 Ϯ 17% of control response) or anti-G␣ 14 (109 Ϯ 21% of control response) was without significant effect compared with control oocytes.
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at ASPET Journals on August 14, 2017 molpharm.aspetjournals.org Downloaded from p Ͻ 0.001, t test). In contrast, in anti-G␣ q -injected cells QX314 had no significant (p ϭ 0.574, t test) inhibitory effect (1.6 Ϯ 0.2 versus 1.7 Ϯ 0.2 A). These findings indicate that QX314 inhibits only when functional G␣ q is present, suggesting that it mediates its inhibitory effect by acting on this G protein subunit.
In contrast to our findings, Noh et al. (1998) reported involvement of G␣ 11 in mediation of LPA responses in X. laevis oocytes. If so, LA inhibition of LPA signaling might also take place at this G protein. We therefore investigated the effect of intracellularly injected QX314 on either water-(control) or anti-G␣ 11 -injected oocytes (Fig. 3D) . Oocytes, injected 48 h prior with water (control), showed an average peak current of 1.95 Ϯ 0.15 A after stimulation with LPA (10 Ϫ7 M). Injection of QX314 at approximately IC 50 (424 ϫ 10 Ϫ6 M) inhibited peak current of control oocytes to 63.1 Ϯ 6.2% of control response. Anti-G␣ 11 injection changed neither the response to LPA (10 Ϫ7 M) alone (96.4 Ϯ 7.2% of control response) nor the effect of QX314 (66.4 Ϯ 6.4% of control response in anti-G␣ 11 -injected oocytes) compared with control cells. Thus, in our hands at least, G␣ 11 seems not to be involved in mediation of the LPA response, and knockdown of G␣ 11 did not affect inhibition of the LPA response by QX314.
These results indicate that intracellularly injected QX314 acts by interference with G protein functioning and that its main target is the G␣ q -subunit, rather than G␣ o or G␣ 11 .
QX314 Inhibition of m1 Muscarinic Signaling also Requires G␣ q . If intracellular QX314 acts selectively on G␣ q , the m1 muscarinic receptor, which couples to this G protein, should be inhibited also by this LA. Since we determined that G␣ q and G␣ 11 are the primary G protein subunits coupling to the m1 muscarinic receptor, we studied the effect of intracellularly injected QX314 in oocytes expressing the m1 muscarinic receptor, 48 h after injection of antisense oligonucleotides directed against G␣ q or G␣ 11 . As shown above, injection of anti-G␣ q or anti-G␣ 11 alone reduced the control response (3.25 Ϯ 0.19 A) (Fig. 4A) , elicited by stimulation of the m1 receptor with MCh (10 Ϫ7 M), to 44 (1.44 Ϯ 0.16 A) and 48% (1.56 Ϯ 0.24 A), respectively. If QX314 acts on G␣ q , its half-maximal inhibition concentration should be independent of the receptor studied. We therefore used QX314 at IC 50 as determined for LPA signaling. Intracellularly injected QX314 (424 ϫ 10 Ϫ6 M) had no significant (p ϭ 0.719, t test, n ϭ 20) effect in G␣ q -degraded oocytes (1.35 Ϯ 0.19 A, 94%), whereas 48 h after anti-G␣ 11 injection it inhibited responses to MCh (0.87 Ϯ 0.15 A) by the appro- priate percentage (55%, p ϭ 0.02, t test, n ϭ 20). Thus, QX314 inhibition is dependent on the presence of G␣ q , and the compound differentiates between two very similar G protein ␣-subunits: G␣ q and G␣ 11 .
Trypsin Signaling is Inhibited by Intracellularly Injected QX314 and Lidocaine. To confirm that the G␣ qsubunit is an intracellular target site for LA, we studied the effect of intracellularly injected QX314 on responses induced by trypsin. Again, we used the IC 50 for QX314 as determined for LPA signaling. Responses of the endogenous protease receptor, elicited by extracellular application of trypsin (1 g/ml) to oocytes revealed a mean response size of 4.34 Ϯ 0.46 A (Fig. 4B) . Ten minutes after injection of QX314 (424 ϫ 10 Ϫ6 M), mean response size was significantly (p ϭ 0.004, t test, n ϭ 20) reduced by 39% to 2.66 Ϯ 0.3 A. This finding indicates that another receptor coupled to G␣ q is inhibited by intracellularly injected QX314, with similar potency as that observed at the LPA receptor. This supports our hypothesis that the G␣ q -subunit is likely to be an intracellular target site for LA.
To confirm that our findings determined for the quaternary lidocaine analog QX314 also hold for tertiary amide LA such as lidocaine, we next determined whether intracellularly injected lidocaine is able to inhibit trypsin-induced responses in the absence of G␣ q or G␣ 14 , both of which were previously determined to be required for this signaling pathway. To prevent possible extracellular effects by lidocaine leaking to the outside, oocytes were superfused with Tyrode's solution at high flow rates (10 ml/min). As shown in Fig. 4C , 48 h after injection of anti-G␣ q or anti-G␣ 14 mean control response (3.49 Ϯ 0.42 A), elicited by extracellular application of trypsin (1 g/ml) to oocytes expressing the endogenous protease receptor, was reduced to 33 (1.16 Ϯ 0.27 A) and 42% (1.46 Ϯ 0.27 A), respectively. Intracellularly injected lidocaine (445 ϫ 10 Ϫ6 M, approximate IC 50 as determined from pilot studies) had no significant (p ϭ 0.294, t test, n ϭ 24) effect on G␣ q -degraded oocytes (1.58 Ϯ 0.29 A, 136%), whereas 48 h after anti-G␣ 14 injection it inhibited responses to trypsin (0.42 Ϯ 0.09 A) by 71%, p ϭ 0.001, t test, n ϭ 22). Thus, inhibition by intracellular lidocaine is also dependent on the presence of G␣ q .
AT 1A Signaling is Primarily Mediated by G␣ o and G␣ 14. We showed previously that AT 1A signaling is not inhibited by LA. If intracellular inhibition of G protein-coupled receptors by LA were due to action on the G␣ q -subunit, we would predict that AT 1A signaling is not primarily mediated by G␣ q in our model. To test our hypothesis, we determined the G protein ␣-subunits coupling to the AT 1A receptor (Fig. 4C) . In oocytes recombinantly expressing the AT 1A receptor, angiotensin II (10 Ϫ6 M) induced an inward chloride current [I Cl(Ca) ] with an average peak current of 2.72 Ϯ 0.29 A, comparable with our previous data (Nietgen et al., 1997). Fourty-eight hours after antisense injection, oocytes injected with anti-G␣ o (59.5 Ϯ 7.4% of control re- Cells injected with the corresponding DNA antisense oligonucleotides (50 ng/oocyte) 48 h prior revealed inhibition of peak current to 59.5 Ϯ 7.4 of control response by anti-G␣ o and 58.5 Ϯ 6.3% of control response by anti-G␣ 14 , whereas injection of anti-G␣ q (78.2 Ϯ 6.4% of control response) or anti-G␣ 11 (105.9 Ϯ 11.4% of control response) was without significant effect compared with control oocytes.
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at ASPET Journals on August 14, 2017 molpharm.aspetjournals.org sponse) or anti-G␣ 14 (58.5 Ϯ 6.3% of control response) showed a significant (p Ͻ 0.05) reduction in peak current. In contrast, injection of anti-G␣ q (78.2 Ϯ 6.4% of control response, p Ͼ 0.05) or anti-G␣ 11 (105.9 Ϯ 11.4% of control response, p Ͼ .05) did not significantly affect responses elicited by stimulation with angiotensin II (10 Ϫ6 M). Thus, although a slight contribution of G␣ q cannot be ruled out, AT 1A receptor signaling is mediated primarily by G␣ o and G␣ 14 . Lack of LA effect on this receptor is therefore compatible with our hypothesis that intracellular inhibition of several G protein-coupled receptors by LA is due to interaction with the G␣ q -subunit.
Discussion
In the present study we have shown that LPA signaling is inhibited by ropivacaine stereoisomers in a concentrationdependent and stereoselective manner, strongly suggesting a protein site of action for ropivacaine. This inhibition is primarily due to a noncompetitive antagonism. We also found that LPA signaling is mediated primarily by G␣ q and G␣ o . G␣ q couples to LPA, muscarinic m1, and trypsin receptors and is a main target for intracellular LA inhibition of G protein-coupled receptors.
As in our previous studies, we used the X. laevis oocyte model. Several potential problems with the technique should be considered when interpreting the data. Using X. laevis oocytes requires performing experiments at room temperature, which raises the question whether the X. laevis LPA receptor and G proteins might behave differently from their mammalian orthologs. However, LPA-induced Ca 2ϩ signaling in oocytes and in mammalian cells has been shown to be similar (Durieux et al., 1992; Moolenaar, 1995) . We have only studied a single form of LPA signaling (Cl Ϫ currents induced by intracellular Ca 2ϩ release), whereas several intracellular signaling cascades are activated by LPA (e.g., decreases in cAMP, activation of Rho and ras). It is possible that these other actions might be affected differently by LA; indeed, this appears likely, as they involve different G␣-subunits in their signaling pathways (e.g., G i mediates LPA-induced decreases in cAMP) (van Corven et al., 1989) . Therefore, our data should not be extrapolated to LPA signaling in general. The m1 muscarinic and the AT 1A angiotensin receptor derive from rat and therefore were expressed at a lower temperature than they normally function in, but this has not been shown to affect their signaling properties appreciably. Although LPA and m1 muscarinic receptors have been shown to couple to G q in mammalian cells, it is important to emphasize that the specificity of G protein coupling may depend on the cell type and species. However, 90% homology between mammalian and frog G proteins and lack of any evidence for differences in the physiological activity of species homologs of those G protein subunits make significant difference unlikely (Filtz et al., 1996) . Despite these caveats, the oocyte model provides great advantages for studies of this kind. Particularly useful in the current context is the ability to study intracellular actions by microinjection of different compounds.
We supported our previous findings, which suggested that LA affect LPA signaling at either the G protein or the receptor itself Sullivan et al., 1999 ) by showing stereoselectivity for ropivacaine inhibition of LPA signaling. This makes an interaction with a protein most likely. It should be realized, however, that phospholipids also contain a chiral carbon and that organized lipid membranes can show significant stereoselectivity (Dickinson et al., 1994) . Interaction of LA with the compound LPA itself is unlikely because we demonstrated inhibition by intracellular QX314, whereas LPA acts extracellularly at its receptor (Sullivan et al., 1999) . Our studies using ropivacaine revealed an additional finding with potential clinical relevance. We found (S-)-ropivacaine to be 6-fold less potent than bupivacaine and 4-fold less potent than lidocaine in inhibiting LPA signaling. Since LPA is likely to play a role in wound healing, LA, when injected around surgical wounds, may impair wound healing by inhibiting LPA signaling. If so, ropivacaine might have advantages over bupivacaine. Moreover, our findings with ropivacaine suggest that the LPA-inhibitory properties of racemic bupivacaine may largely reside in the clinically irrelevant stereoisomer dextrobupivacaine, suggesting that levobupivacaine would have fewer detrimental effects on wounds than the racemic preparation.
We found LPA signaling to be mediated mainly by G␣ o and G␣ q . In contrast, Noh et al. (1998) reported involvement of G␣ q and G␣ 11 in mediation of the LPA response in X. laevis oocytes. This inconsistency might be explained by the different antisense oligonucleotides used. Cross-degradation of other G protein ␣-subunits was not evaluated in Noh's study, whereas our experiments were performed with antisense sequences for which cross reactions with other G protein ␣-subunits have been determined on the mRNA and protein level (Shapira et al., 1999) . In other words, whereas Noh et al. can not exclude that the reduction of LPA peak currents after injection of anti-G␣ 11 is in fact caused by degradation of [highly similar (Stehno-Bittel et al., 1995) ] G␣ q , we can rule out that anti-G␣ 11 and anti-G␣ 14 had effects on the other G protein ␣-subunits. In addition, it is not surprising that they did not observe involvement of G␣ o in the LPA signaling pathway, because it was not, or only in small amounts, present in their oocytes.
Antisense results should not be overinterpreted in a quantitative manner. Specifically, although adding the percentage of inhibition obtained by anti-G␣ o and anti-G␣ q suggests complete inhibition of the LPA response when both G proteins are depleted, involvement of other G proteins can not be ruled out. For example, data from Shapira et al. (1999) would predict that combined G␣ q and G␣ 14 depletion would inhibit trypsin signaling by 140% (69% by anti-G␣ q and 68% by anti-G␣ 14 ). In reality, when both antisense oligonucleotides were injected in combination, a 7% response to trypsin remained (Shapira et al., 1999) . The underlying mechanisms may be several. Degradation of the G protein subunit may be incomplete, and the percentage of G protein ␣-subunit degradation may not necessarily correlate with the percentage of response inhibition. As stated by Shapira et al., it cannot be excluded that even residual amounts of any G protein can mediate a full response (Shapira et al., 1999) . In addition, other G protein ␣-subunits, like G␣ 11 and/or G␣ 14 , which are usually not involved in the mediation of the LPA response when G␣ q and/or G␣ o are present, may be recruited when G␣ q and G␣ o are depleted. We attempted to determine the effect of combined injection of anti-G␣ q and anti-G␣ o , but most cells died and most surviving oocytes did not show a Our previous studies (Hollmann et al., 1999; Sullivan et al., 1999) suggest that intracellular LA affect several G protein-coupled receptors with different structure (muscarinic m1 and LPA receptors) in a similar manner, making the G protein as a target most likely [because we have shown lack of interaction with the distal signaling pathway Sullivan et al., 1999) ]. Our results in the present study confirm this hypothesis. The significant inhibitory effect of intracellular QX314 on G␣ o -depleted (LPA signaling) and G␣ 11 -depleted (m1 muscarinic signaling) cells, and of intracellularly applied lidocaine in G␣ 14 -depleted (trypsin signaling) cells, contrasted with the lack of LA effect on G␣ q -degraded cells, suggests that LA might act intracellularly by inhibiting G␣ q signaling. This is consistent with our findings that all three LA-sensitive receptors (muscarinic m1, LPA, and trypsin receptors) couple to G␣ q and that those structurally completely different receptors are inhibited to a similar degree by intracellularly injected QX314. In contrast, the angiotensin 1 A receptor, which is not inhibited by LA, was found not to couple to G␣ q to an appreciable degree.
Our results are consistent with findings by Xiong et al. (1999) , who investigated LA inhibition of G protein-mediated modulation of potassium and calcium currents in anterior pituitary cells from rats. They demonstrated that lidocaine acts between agonist binding and G protein activation and concluded that such inhibition of G protein pathways might be an important component of the general action of LA (Xiong et al., 1999) .
In conclusion, our study suggests that G protein-coupled receptors may be common targets for local anesthetics. The concentrations used in this study are routinely attained after local injection of these compounds. Inhibition of G proteincoupled receptors by LA results in part from an intracellular action, which can be largely explained by selective interference with G␣ q function.
